PharmaNet hires vp for clinical operations
Catherine Derasp will oversee Phase I clinics
Derasp will oversee the management of the company's 350-bed Phase I clinical operations that are located in Montreal and Quebec City, Canada. In addition to first-in-man and proof-of-concept phase I clinical services, she will be responsible for a variety of studies in special populations, cardiac safety testing, and drug-drug interaction studies.
You may also like
Pharmaceutical
![CellCarta adds Tempus to companion diagnostic commercialisation network]()
CellCarta adds Tempus to companion diagnostic commercialisation network
CellCarta has partnered with Tempus to expand its CDx Commercialization Lab Network, giving biopharma sponsors a route from companion diagnostic development and regulatory approval to commercial testing in US oncology practice
Manufacturing
![FDA escalates action against Dabur India over systemic data-integrity and cGMP failures]()
FDA escalates action against Dabur India over systemic data-integrity and cGMP failures
The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process validation and weaknesses in quality-unit oversight, saying the company's response failed to address the systemic nature of the deficiencies
Regulatory
![Aravax secures FDA Fast Track designation for peanut allergy immunotherapy PVX108]()
Aravax secures FDA Fast Track designation for peanut allergy immunotherapy PVX108
The designation accelerates development of the peptide-based immunotherapy, which is designed to retrain immune tolerance to peanuts without triggering acute allergic reactions — with Phase II data expected later this year
